Molecular genetic insights into sporadic primary hyperparathyroidism

Area of Science:

• Endocrinology
• Oncology
• Molecular Genetics

Background:

• Primary hyperparathyroidism (PHPT) is a common endocrine disorder due to parathyroid hormone dysregulation.
• Most PHPT cases stem from sporadic parathyroid adenomas, driven by MEN1 and CCND1/cyclin D1.
• Sporadic parathyroid carcinoma, often driven by CDC73 (HRPT2) inactivation, follows distinct molecular pathways.

Purpose of the Study:

• To review molecular genetic abnormalities in sporadic PHPT.
• To discuss the evidence for identified genes in parathyroid tumor formation.
• To highlight the genetic heterogeneity of parathyroid neoplasia.

Main Methods:

• Review of targeted gene investigations in parathyroid tumors.
• Analysis of whole-genome and exome sequencing data from small patient cohorts.
• Evaluation of existing literature on genetic drivers of parathyroid neoplasia.

Main Results:

• Established drivers like MEN1, CCND1/cyclin D1, and CDC73 (HRPT2) are key in parathyroid tumorigenesis.
• Numerous novel candidate genes have been identified in sporadic parathyroid neoplasia.
• These additional candidates exhibit low to modest mutational frequencies, indicating tumor-specific genetic heterogeneity.

Conclusions:

• The molecular landscape of sporadic PHPT is complex, with distinct pathways for adenomas and carcinomas.
• Further experimental validation is needed to confirm the in vivo roles of newly identified candidate genes.
• Understanding these genetic abnormalities is crucial for advancing PHPT research and potential therapies.